About
Inhalis Therapeutics develops inhaled drug formulations and delivery technologies targeting idiopathic pulmonary fibrosis and other serious respiratory diseases.
Explore Inhalis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.